Trials / Completed
CompletedNCT01004107
Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation
Phase 4, Evaluation of Radiesse® Dermal Filler for Hand Rejuvenation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.
Detailed description
This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment. This is a prospective, randomized, masked, controlled study to investigate the effectiveness of Radiesse® Dermal Filler for hand treatment, comprised of a 3-month main study followed by an open-label extension (OLEX) study through 12 months. At 3 months, untreated controls received Radiesse Dermal Filler for hand treatment and were followed for the remainder of the study. All study subjects were eligible for retreatment 6 months after initial treatment, and all subjects were followed through 12 months from study enrollment in the OLEX.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiesse Injectable Dermal Filler | Calcium hydroxylapatite particles suspended in an aqueous-based gel carrier |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2009-10-29
- Last updated
- 2018-07-13
- Results posted
- 2018-07-13
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01004107. Inclusion in this directory is not an endorsement.